Soleus Capital Management, L.P. Smith & Nephew PLC Transaction History

Soleus Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$21.55 - $27.43 $3.96 Million - $5.04 Million	-183,702 Reduced 28.09%	470,198 $12.8 Million
Q3 2023 Nov 14, 2023	BUY	$24.33 - $31.28 $4.01 Million - $5.15 Million	164,632 Added 33.65%	653,900 $16.2 Million
Q2 2023 Aug 14, 2023	SELL	$28.08 - $32.7 $13.5 Million - $15.7 Million	-480,932 Reduced 49.57%	489,268 $15.8 Million
Q1 2023 May 15, 2023	BUY	$27.29 - $29.4 $26.5 Million - $28.5 Million	970,200 New	970,200 $27.1 Million
Q2 2022 Aug 15, 2022	SELL	$27.53 - $33.71 $10.6 Million - $13 Million	-385,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$30.84 - $36.38 $6.42 Million - $7.57 Million	-208,200 Reduced 35.1%	385,000 $12.3 Million
Q4 2021 Feb 14, 2022	BUY	$31.98 - $37.15 $19 Million - $22 Million	593,200 New	593,200 $20.5 Million

223

30.2M

900

6.6K

Ticker SNN
Exchange OTC
Sector Healthcare
Industry Medical Devices
Shares Outstandng 435,348,000
Market Cap $11B
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.